Targeting the ChREBP/PKLR-lactate axis via Huachansu tablets restores CD8⁺T cell immunity in MASH-HCC
Pharmacological Research · 2026-11 · 233 · 108448
DOI: 10.1016/j.phrs.2026.108448 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacological Research, 2026-11. Verfasst von Yueyue Li und 13 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Xin'an Medicine, Ministry of Education, School of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230038, China. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Lactic Acid, Liver Neoplasms, Carcinoma, Hepatocellular. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Bengbu Medical University, Anhui University of Chinese Medicine.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Xin'an Medicine, Ministry of Education, School of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230038, China.
- Anhui Academy of Medical Sciences, Anhui Institute of Medicine, Hefei, 230061, China.
- Department of Biochemistry and Molecular Biology, School of Laboratory Medicine, and Anhui Provincial Key Laboratory of Tumor Evolution and Intelligent Diagnosis and Treatment, Bengbu Medical University, 2600 Donghai Av…
- Anhui China Resources Jinchan Pharmaceutical Co., Ltd., Anhui, 235000, China. Electronic address: luochuan@999.com.cn.
- Key Laboratory of Xin'an Medicine, Ministry of Education, School of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230038, China. Electronic address: wangmeng@ahtcm.edu.cn.
- Key Laboratory of Xin'an Medicine, Ministry of Education, School of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230038, China; Bozhou Vocational and Technical College, Bozhou, Anhui, 236800, China. Electronic…
Förderung
- National Natural Science Foundation of China
- Bengbu Medical University
- Anhui University of Chinese Medicine
- Anhui Provincial Natural Science Foundation
Zitieren
APA
Li, Y., Ma, J., Peng, W., Lv, Z., Liang, X., Li, S., Wang, M., Su, J., Luo, S., Gu, W., Cheng, H., Luo, C., Wang, M., & Li, Q. (2026). Targeting the ChREBP/PKLR-lactate axis via Huachansu tablets restores CD8⁺T cell immunity in MASH-HCC. Pharmacological Research, 233, 108448. https://doi.org/10.1016/j.phrs.2026.108448
Vancouver
Li Y, Ma J, Peng W, Lv Z, Liang X, Li S, et al. Targeting the ChREBP/PKLR-lactate axis via Huachansu tablets restores CD8⁺T cell immunity in MASH-HCC. Pharmacological Research. 2026;233:108448. doi:10.1016/j.phrs.2026.108448
BibTeX
@article{Li2026,
author = {Li, Yueyue and Ma, Jingjing and Peng, Weitong and Lv, Zhengxiang and Liang, Xinmeng and Li, Shanshan and Wang, Manman and Su, Jingjing and Luo, Shengyong and Gu, Wei and Cheng, Hui and Luo, Chuan and Wang, Meng and Li, Qinglin},
title = {Targeting the ChREBP/PKLR-lactate axis via Huachansu tablets restores CD8⁺T cell immunity in MASH-HCC},
journal = {Pharmacological Research},
year = {2026},
volume = {233},
pages = {108448},
doi = {10.1016/j.phrs.2026.108448}
}
EUVIMED